Carson Wealth (CWM LLC)
MAZE

Carson Wealth (CWM LLC)’s Maze Therapeutics MAZE Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64K Sell
2,143
-86
-4% -$3.79K ﹤0.01% 3626
2025
Q4 		$92K Buy
2,229
+91
+4% +$3.13K ﹤0.01% 3132
2025
Q3 		$55K Sell
2,138
-128
-6% -$2.16K ﹤0.01% 3456
2025
Q2 		$28K Buy
+2,266
New +$23.6K ﹤0.01% 3703

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Carson Wealth (CWM LLC)'s MAZE Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Maze Therapeutics (MAZE) stake by 3.9% in Q1 2026, selling an estimated $3.79K and leaving 2,143 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #3626.

Carson Wealth (CWM LLC) first reported a position in MAZE in Q2 2025 and has held it in 4 quarters since. The position peaked at $92K in Q4 2025. 165 funds tracked by Wall St. Rank hold MAZE as of Q1 2026.

  • Carson Wealth (CWM LLC) held 2,143 shares of Maze Therapeutics worth $64K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 86 Maze Therapeutics shares in Q1 2026, an estimated $3.79K.
  • Maze Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3626 holding.
  • Carson Wealth (CWM LLC) first reported a position in Maze Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Carson Wealth (CWM LLC)'s Maze Therapeutics position peaked at $92K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Maze Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.